​

Funding Round

Series A - Leucid Bio

Series A - Leucid Bio

Investment Firm

Overview

Leucid is progressing novel cart therapies that produce a better and more durable response.

Announced Date

Oct 21, 2021

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

Epidarex Capital

Epidarex Capital

Epidarex Capital is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorEpidarex Capital
Participant InvestorVulpes Investment Management Pte Ltd
Participant InvestorBritish Business Bank
Participant InvestorSofinnova Partners

Round Details and Background

Leucid Bio raised $15860166 on 2021-10-21 in Series A

Leucid is progressing novel cart therapies that produce a better and more durable response.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 21, 2021
Series A - Leucid Bio
5-15.9M

Recent Activity

There is no recent news or activity for this profile.